Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Trey C. Mullikin, MD"'
Autor:
Jim X. Leng, MD, David J. Carpenter, MD, MS, Christina Huang, MD, MS, Jamiluddin Qazi, MD, Muzamil Arshad, MD, PhD, Trey C. Mullikin, MD, Zachary J. Reitman, MD, PhD, John P. Kirkpatrick, MD, PhD, Scott R. Floyd, MD, PhD, Peter E. Fecci, MD, PhD, Steven J. Chmura, MD, PhD, Julian C. Hong, MD, MS, Joseph K. Salama, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 6, Pp 101475- (2024)
Purpose: Clinical and imaging surveillance of patients with brain metastases is important after stereotactic radiosurgery (SRS) because many will experience intracranial progression (ITCP) requiring multidisciplinary management. The prognostic signif
Externí odkaz:
https://doaj.org/article/9b2b1cb3961e4e0cb8af8646f35e79da
Autor:
Justin D. Anderson, MD, Molly M. Voss, Brady S. Laughlin, MD, Allison E. Garda, MD, Khaled Aziz, Trey C. Mullikin, MD, Michael G. Haddock, MD, Ivy A. Petersen, MD, Todd A. DeWees, PhD, Sujay A. Vora, MD
Publikováno v:
International Journal of Particle Therapy, Pp 10-17 (2022)
Purpose: To compare Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in patients with endometrial cancer receiving adjuvant pelvic radiation therapy with proton beam therapy (PT) versus intensity-mod
Externí odkaz:
https://doaj.org/article/958b96070e504a4e9ae8910b409592ed
Autor:
David J. Carpenter, MD, Andrew T. Fairchild, MD, Justus D. Adamson, PhD, Peter E. Fecci, MD, PhD, John H. Sampson, MD, PhD, James E. Herndon, II, PhD, Jordan A. Torok, MD, Trey C. Mullikin, MD, Grace J. Kim, MD, PhD, Zachary J. Reitman, MD, PhD, John P. Kirkpatrick, MD, PhD, Scott R. Floyd, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 2, Pp 101166- (2023)
Purpose: Hypofractionated stereotactic radiosurgery (HF-SRS) with or without surgical resection is potentially a preferred treatment for larger or symptomatic brain metastases (BMs). Herein, we report clinical outcomes and predictive factors followin
Externí odkaz:
https://doaj.org/article/1cb1e0491df74d279463abda04494634
Autor:
J. John Lucido, PhD, Trey C. Mullikin, MD, Feven Abraha, BS, W. Scott Harmsen, MS, Birjoo D. Vaishnav, PhD, Debra H. Brinkmann, PhD, Roman O. Kowalchuk, MD, Joseph T. Marion, MD, Benjamin A. Johnson-Tesch, MD, Omar El Sherif, PhD, Paul D. Brown, MD, Peter S. Rose, MD, Dawn Owen, MD, PhD, Jonathan M. Morris, MD, Mark R. Waddle, MD, Brittany L. Siontis, MD, Bradley J. Stish, MD, PhD, Deanna H. Pafundi, PhD, Nadia N. Laack, MD, Kenneth R. Olivier, MD, Sean S. Park, MD, PhD, Kenneth W. Merrell, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 101047- (2022)
Purpose: This study reports on the risk of radiation-induced myelitis (RM) of the spinal cord from a large single-institutional experience with 1 to 5 fraction stereotactic body radiation therapy (SBRT) to the spine. Methods and Materials: A retrospe
Externí odkaz:
https://doaj.org/article/38944510161c4d8c897a8c02856135e9
Autor:
Ashley Hunzeker, MS, CMD, Daniel W. Mundy, PhD, Jiasen Ma, PhD, Trey C. Mullikin, MD, Robert L. Foote, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 304-310 (2021)
Purpose: To successfully plan and treat a patient with diffuse angiosarcoma involving the face and scalp with intensity-modulated proton therapy (IMPT) before surgical resection. Materials and Methods: A patient presented to the radiation oncology de
Externí odkaz:
https://doaj.org/article/00c2f71b18004ea29e81f8cb516c3853
Autor:
Trey C. Mullikin, MD, Kay M. Pepin, PhD, Jaden E. Evans, MD, Sudhakar K. Venkatesh, MD, Richard L. Ehman, MD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, William S. Harmsen, MS, Michael G. Herman, PhD, Christopher L. Hallemeier, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100793- (2021)
Purpose: Magnetic resonance (MR) elastography (E) is a noninvasive technique for quantifying liver stiffness (LS) for fibrosis. This study evaluates whether LS is associated with risk of developing radiation-induced liver disease (RILD) in patients r
Externí odkaz:
https://doaj.org/article/38f84dbf49864b5caaac3bd31a74fbcc
Autor:
Ronik S. Bhangoo, MD, Trey C. Mullikin, MD, Jonathan B. Ashman, MD, PhD, Tiffany W. Cheng, BA, Michael A. Golafshar, MS, Todd A. DeWees, PhD, Jedediah E. Johnson, PhD, Satomi Shiraishi, PhD, Wei Liu, PhD, Yanle Hu, PhD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, Sunil Krishnan, MD, William G. Rule, MD, Terence T. Sio, MD, Christopher L. Hallemeier, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100675- (2021)
Purpose: Our purpose was to assess the safety and efficacy of intensity modulated proton therapy (IMPT) for the treatment of hepatocellular carcinoma (HCC). Methods and Materials: A retrospective review was conducted on all patients who were treated
Externí odkaz:
https://doaj.org/article/9d5f8333dc68426f8f448e1352fed9ab